Cutaneous malignant melanoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
Authors:
Open Access
- 1 May 2009
- journal article
- review article
- Published by Elsevier in Annals of Oncology
- Vol. 20 (suppl_4) , iv129-iv131
Abstract
The incidence of malignant melanoma varies from 3–5/100 000/year in Mediterranean countries to 12–20/100 000/year in Nordic countries. The mortality rate is 2/100 000/year for females and 3/100 000/year for males with a lesser variation with geography. Melanoma mortality has doubled in males over the last 25 years, during which time a trend of declining incidence and mortality in high-risk Northern European countries combined with a continuing increase in Southern Europe has emerged [1]. Increased ultraviolet-B ray exposure of a genetically predisposed population seems responsible for an ongoing increase in incidence over recent decades [2].Keywords
This publication has 17 references indexed in Scilit:
- Adjuvant treatment with vindesine in comparison to observation alone in patients with metastasized melanoma after complete metastasectomy: a randomized multicenter trial of the German Dermatologic Cooperative Oncology GroupMelanoma Research, 2008
- Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative settingMelanoma Research, 2008
- Why perform sentinel-lymph-node biopsy in patients with melanoma?Nature Clinical Practice Oncology, 2008
- Melanoma incidence and mortality in Scotland 1979–2003British Journal of Cancer, 2007
- Sentinel-Node Biopsy or Nodal Observation in MelanomaNew England Journal of Medicine, 2006
- Micro-melanoma detection: a clinical study on 206 consecutive cases of pigmented skin lesions with a diameter ≤ 3 mmBritish Journal of Dermatology, 2006
- Temozolomide in Combination With Interferon-Alfa Versus Temozolomide Alone in Patients With Advanced Metastatic Melanoma: A Randomized, Phase III, Multicenter Study from the Dermatologic Cooperative Oncology GroupJournal of Clinical Oncology, 2005
- Cutaneous melanomaThe Lancet, 2005
- Final results of the EORTC 18871/DKG 80-1 randomised phase III trialEuropean Journal of Cancer, 2004
- Changing epidemiology of malignant cutaneous melanoma in Europe 1953–1997: Rising trends in incidence and mortality but recent stabilizations in Western Europe and decreases in ScandinaviaInternational Journal of Cancer, 2003